
SUPPLIER READINESS
Know what your records support.
Bioactiva Supplier Readiness connects buyer questions to quality records, evidence gaps and next steps. For independent excipient manufacturers. Our Diagnostic is in preparation.
Prepare clearer answers for buyer qualification.
Bioactiva Supplier Readiness helps your team understand which buyer questions your quality documents answer, what is missing, and what to address next. It is a service line of Bioactiva Solutions, a founder-led advisory business.
The Market Readiness Diagnostic starts with a defined buyer qualification and the documents you approve for review. We connect the evidence, record gaps and inconsistencies, and set out findings and next actions. Findings apply only to the agreed supplier, site, grade, buyer decision, approved records and review cutoff date.
We are not yet accepting public requests for the Diagnostic. For general questions, email hq@bioactivasolutions.com. Please do not send confidential records through this website or by email.
One decision pack. Six connected outputs.
Understand the findings
The Executive Decision Brief summarizes the findings, limits and recommended actions. The Readiness and Evidence Workbook links findings to approved documents, gaps and responsible people.
Connect questions to actions
The Excipient Evidence Crosswalk and Reviewer Record maps buyer questions to evidence and reviewer checks. The Thirty-Day Action Register sets out priorities, owners, dependencies and target dates.
Review the next steps together
The Findings Workshop gives your team time to discuss the findings and next steps. The Controlled Handoff Record lists delivered files, open questions and review or correction dates.
Is the current Diagnostic for you?
Our initial focus is independent excipient manufacturers with an active initial qualification involving one named U.S. drug-product manufacturer, contract development and manufacturing organization, or authorized distributor. The scope covers one manufacturing site and one established, non-sterile, non-novel, compendial grade used in oral solid medicines. Compendial means an official pharmacopeia publishes a standard for the excipient; this review does not confirm conformity. Other products and routine requalification are outside the initial scope.
Responsibilities and limits
An independent qualified reviewer must be designated before a Diagnostic begins and may stop work if required controls are not met. Your company is responsible for its facts, decisions and final submissions. The buyer decides qualification, trials, approval and purchasing.
The Diagnostic does not certify readiness or compliance, approve suppliers or products, perform laboratory testing, complete buyer portals, submit information on your behalf, or act as an importer or Foreign Supplier Verification Program agent. Qualified specialists retain legal, regulatory, laboratory, audit, certification, import, compendial and Good Manufacturing Practice decisions. Bioactiva does not promise acceptance, trials, purchases, timing, revenue or market access.
General inquiries
For general questions about Bioactiva Supplier Readiness, email hq@bioactivasolutions.com. Please do not send confidential records. We are not yet accepting public requests for the Diagnostic.